Supporting medicines management in older adults with multiple medical conditions
- Conditions
- Polypharmacy and multimorbiditySigns and Symptoms
- Registration Number
- ISRCTN12752680
- Lead Sponsor
- The Health Research Board - Centre for Primary Care Research (Ireland)
- Brief Summary
2017 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/28764753 protocol 2019 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/32104779 process evaluation protocol (added 28/02/2020) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/34986166/ (added 06/01/2022) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36245339/ Process evaluation (added 18/10/2022) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36385206/ secondary analysis (added 18/11/2022) 2023 Results article in https://doi.org/10.1093/fampra/cmad039 Recruiting general practitioners and older patients with multimorbidity to randomized trials (added 05/04/2023) 2024 Results article in https://pubmed.ncbi.nlm.nih.gov/39190222/ Cost effectiveness (added 02/09/2024)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 404
Practice inclusion criteria:
1. Have 300 or more older patients (aged =65 years) on their patient panel (based on the need to identify at least 15 patients per practice who are receiving 15 or more medicines and allowing for refusals)
2. Use Socrates or Health One as a practice management system
Patient inclusion crtieria:
1. Aged 65 years and over
2. Being prescribed at least 15 regular medications
Practice exclusion criteria:
Involved in the development and piloting of the intervention or other concurrent medication quality related studies
Patient exclusion criteria:
1. Significant mental or physical illness that would impair their ability to consent and take part in the study
2. Unable to attend the surgery for medication review (e.g. nursing home residents)
3. Those involved in another medication study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Number of repeat medications are measured through medical record review at baseline and 6 months post-intervention<br>2. Proportion of patients with any potentially inappropriate prescription (PIP) (defined by explicit criteria, used for OPTI-SCRIPT which were based on more prevalent STOPP-START PIP indicators) are measured through medical record review at baseline and 6 months post-intervention
- Secondary Outcome Measures
Name Time Method